mebendazole for cancer | Mebendazole: Can It Help Fight Cancer…

Keyword	CPC	PCC	Volume	Score	Length of keyword
mebendazole for cancer	0.02	1	2850	42	22
mebendazole	0.42	0.9	9557	64	11
for	1.38	0.2	9439	39	3
cancer	0.7	0.2	4011	64	6

Keyword	CPC	PCC	Volume	Score
mebendazole for cancer	0.43	0.7	915	36
mebendazole for cancer treatment	0.11	0.5	6115	58
mebendazole for cancer at cvs	0.69	0.7	9337	95
mebendazole for cancer clinical trials	0.96	0.9	3413	33
mebendazole vs fenbendazole for cancer	0.64	0.7	7811	66
mebendazole dose for cancer	1.66	0.5	3035	99
mebendazole dosage for cancer treatment	0.1	0.1	5864	98
fenbendazole and mebendazole for cancer	0.12	0.2	8987	92
mebendazole for breast cancer	0.57	0.2	8711	4
how to take mebendazole for cancer	1.93	1	2708	75
mebendazole for human cancer	0.17	0.4	8001	2

Search Results related to mebendazole for cancer on Search Engine

Mebendazole: Can It Help Fight Cancer…
anticancer360.com

https://anticancer360.com/mebendazole-can-it-help-fight-cancer/

DA: 11 PA: 51 MOZ Rank: 1

Mebendazole prevents distant organ metastases in part by ... - PubMed
nih.gov

https://pubmed.ncbi.nlm.nih.gov/36578038/

DA: 30 PA: 75 MOZ Rank: 61

Mebendazole | Memorial Sloan Kettering Cancer Center
mskcc.org

https://www.mskcc.org/cancer-care/patient-education/medications/adult/mebendazole

WEBDec 12, 2022 · Mebendazole is a medication used to treat infections caused by worms. It is not used for cancer treatment and has some side effects and interactions that you should know before taking it.

DA: 72 PA: 58 MOZ Rank: 76

Emerging Perspectives on the Antiparasitic …
nih.gov

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9862092/

WEBJan 10, 2023 · Mebendazole can penetrate the blood–brain barrier and has been shown to inhibit the malignant progression of glioma by targeting signaling pathways related to … DOI: 10.3390/ijms24021334 Published: 2023/01 Publication: Int J Mol Sci. 2023 Jan; 24(2): 1334.

DOI: 10.3390/ijms24021334
Published: 2023/01
Publication: Int J Mol Sci. 2023 Jan; 24(2): 1334.

DA: 63 PA: 15 MOZ Rank: 75

Explore further
nih.gov

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9862092/

DA: 58 PA: 93 MOZ Rank: 11

A phase 2a clinical study on the safety and efficacy of
nature.com

https://www.nature.com/articles/s41598-021-88433-y

WEBApr 26, 2021 · Mebendazole is used extensively for treatment of local gut helminthic and invasive echinococcus infections. Anticancer effects of … Author: Sharmineh Mansoori, Mårten Fryknäs, Carina Alvfors, Angelica Loskog, Rolf Larsson, Peter Nygren Publish Year: 2021

Author: Sharmineh Mansoori, Mårten Fryknäs, Carina Alvfors, Angelica Loskog, Rolf Larsson, Peter Nygren
Publish Year: 2021

DA: 32 PA: 38 MOZ Rank: 33

Mebendazole as a Candidate for Drug Repurposing in …
nih.gov

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6769799/

WEBAug 31, 2019 · Mebendazole was more potent as an antiproliferative agent against gastric cancer cell lines (IC50 0.39–1.25 μM) than several other clinically approved … Author: Andrea Emanuele Guerini, Luca Triggiani, Marta Maddalo, Marco Lorenzo Bonù, Francesco Frassine, Anna... DOI: 10.3390/cancers11091284 Publish Year: 2019 Publication: Cancers (Basel). 2019 Sep; 11(9): 1284.

Author: Andrea Emanuele Guerini, Luca Triggiani, Marta Maddalo, Marco Lorenzo Bonù, Francesco Frassine, Anna...
DOI: 10.3390/cancers11091284
Publish Year: 2019
Publication: Cancers (Basel). 2019 Sep; 11(9): 1284.

DA: 20 PA: 97 MOZ Rank: 86

Johns Hopkins Study: Anti-Parasitic Drug Slows …
hopkinsmedicine.org

https://www.hopkinsmedicine.org/news/newsroom/news-releases/2021/08/johns-hopkins-study-anti-parasitic-drug-slows-pancreatic-cancer-in-mice

WEBAug 3, 2021 · Mebendazole, an anti-parasitic drug, inhibits tubulin formation and reduces inflammation in pancreatic cancer cells, according to a study by Johns …

DA: 88 PA: 25 MOZ Rank: 62

Repurposing Drugs in Oncology (ReDO)—mebendazole …
nih.gov

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4096024/

WEBJul 10, 2014 · Abstract. Mebendazole, a well-known anti-helminthic drug in wide clinical use, has anti-cancer properties that have been elucidated in a broad range of pre …

DA: 67 PA: 48 MOZ Rank: 5

Mebendazole prevents distant organ metastases in part …
nih.gov

https://pubmed.ncbi.nlm.nih.gov/36578038/

WEBDec 28, 2022 · To advance current therapeutics, we repurposed mebendazole (MBZ), an orally available FDA-approved anthelmintic that has shown preclinical efficacy for …

DA: 76 PA: 51 MOZ Rank: 37

Emerging Perspectives on the Antiparasitic …
nih.gov

https://pubmed.ncbi.nlm.nih.gov/36674870/

WEBJan 10, 2023 · Mebendazole can penetrate the blood-brain barrier and has been shown to inhibit the malignant progression of glioma by targeting signaling pathways related to cell …

DA: 97 PA: 89 MOZ Rank: 11

Mebendazole in recurrent glioblastoma: Results of a phase 2 …
ascopubs.org

https://ascopubs.org/doi/10.1200/JCO.2022.40.16_suppl.2029

WEBJun 2, 2022 · 2029. Background: Recurrent glioblastoma (GBM) has dismal outcomes and limited treatment options. Mebendazole (MBZ) is an anti-helminthic drug with in-vivo …

DA: 42 PA: 64 MOZ Rank: 24

Mebendazole prevents distant organ metastases in part …
biomedcentral.com

https://breast-cancer-research.biomedcentral.com/articles/10.1186/s13058-022-01591-3

WEBOpen access. Published: 28 December 2022. Mebendazole prevents distant organ metastases in part by decreasing ITGβ4 expression and cancer stemness. Natalie S. …

DA: 30 PA: 83 MOZ Rank: 20